Literature DB >> 9396455

Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9.

R D Kenagy1, C E Hart, W G Stetler-Stevenson, A W Clowes.   

Abstract

BACKGROUND: Migration of arterial smooth muscle cells (SMCs) is regulated by basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), and matrix metalloproteinases (MMPs) in the injured rat carotid artery. We have recently shown that migration of SMCs from baboon aortic explants depends on the activity of MMPs, but the identity of the stimulatory MMPs and the role of bFGF and PDGF in this primate system are not known. METHODS AND
RESULTS: These experiments were designed to determine whether MMP2, MMP9, bFGF, or PDGF plays a role in SMC migration from medial explants of baboon aorta. Explants were cultured in serum-free medium with insulin, transferrin, and ovalbumin. Neutralizing antibodies to MMP2 and antibodies that inhibit activation of proMMP9 decreased SMC migration from the aortic explants. Antibodies to bFGF and to the alpha- and beta-subunits of the PDGF receptor also inhibited migration from the explants. Addition of bFGF and PDGF-BB but not PDGF-AA increased migration. The antibodies to bFGF but not the antibodies to the PDGF receptor subunits decreased the levels of MMP9, whereas all the antibodies decreased activated MMP2.
CONCLUSIONS: These data demonstrate that SMC migration from primate aortic explants is dependent on endogenous MMP2, MMP9, PDGF, and bFGF. The data also suggest that PDGF-induced (PDGF-BB or possibly PDGF-AB) migration is dependent on MMP2, whereas bFGF-induced migration depends on both MMP2 and MMP9.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396455     DOI: 10.1161/01.cir.96.10.3555

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury.

Authors:  Bernard S Buetow; Kristen A Tappan; Jeffrey R Crosby; Ronald A Seifert; Daniel F Bowen-Pope
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 2.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

3.  Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms.

Authors:  Matthew R Alexander; Meera Murgai; Christopher W Moehle; Gary K Owens
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

4.  Myosin light chain kinase (MLCK) regulates cell migration in a myosin regulatory light chain phosphorylation-independent mechanism.

Authors:  Chen Chen; Tao Tao; Cheng Wen; Wei-Qi He; Yan-Ning Qiao; Yun-Qian Gao; Xin Chen; Pei Wang; Cai-Ping Chen; Wei Zhao; Hua-Qun Chen; An-Pei Ye; Ya-Jing Peng; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2014-08-13       Impact factor: 5.157

5.  Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients.

Authors:  Milica Bozic; Angels Betriu; Marcelino Bermudez-Lopez; Alberto Ortiz; Elvira Fernandez; Jose M Valdivielso
Journal:  Clin J Am Soc Nephrol       Date:  2018-03-08       Impact factor: 8.237

6.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

7.  Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo.

Authors:  Andrew W Hoel; Peng Yu; Khanh P Nguyen; Xinxin Sui; Janet Plescia; Dario C Altieri; Michael S Conte
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

8.  Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth.

Authors:  Marten Falkenberg; Clifford Tom; Mary Beth DeYoung; Shan Wen; Ruth Linnemann; David A Dichek
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

9.  S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4.

Authors:  Edda Spiekerkoetter; Christophe Guignabert; Vinicio de Jesus Perez; Tero-Pekka Alastalo; Janine M Powers; Lingli Wang; Allan Lawrie; Noona Ambartsumian; Ann-Marie Schmidt; Mark Berryman; Richard H Ashley; Marlene Rabinovitch
Journal:  Circ Res       Date:  2009-08-27       Impact factor: 17.367

10.  Role of formic receptors in soluble urokinase receptor-induced human vascular smooth muscle migration.

Authors:  Enrico A Duru; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2015-02-12       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.